» Authors » Prashanth Chikkahonnaiah

Prashanth Chikkahonnaiah

Explore the profile of Prashanth Chikkahonnaiah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 14
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bansal N, Arunachala S, Ullah M, Kulkarni S, Ravindran S, ShankaraSetty R, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064155
: Pulmonary tuberculosis (TB) remains a major public health issue in India, with high incidence and mortality. The current literature on post-TB sequelae functional defects focuses heavily on spirometry, with...
2.
Chikkahonnaiah P, Dallavalasa S, Tulimilli S, Dubey M, Byrappa S, Amachawadi R, et al.
Diseases . 2024 Jul; 12(7). PMID: 39057114
Diabetes mellitus (DM) is a common comorbidity in COVID-19 subjects. Hyperglycemia at hospital admission identified as a major risk factor and is responsible for poor prognosis. Hematological and inflammatory parameters...
3.
Tulimilli S, Dallavalasa S, Basavaraju C, Rao V, Chikkahonnaiah P, Madhunapantula S, et al.
Vaccines (Basel) . 2022 Oct; 10(10). PMID: 36298616
The incidence and death toll due to SARS-CoV-2 infection varied time-to-time; and depended on several factors, including severity (viral load), immune status, age, gender, vaccination status, and presence of comorbidities....
4.
Korishettar G, Chikkahonnaiah P, Tulimilli S, Dallavalasa S, Byrappa S, Madhunapantula S, et al.
Vaccines (Basel) . 2022 Jul; 10(7). PMID: 35891289
Vaccines against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection, which causes coronavirus disease-19 (COVID-19) in humans, have been developed and are being tested for safety and efficacy. We conducted the...